Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Julia Sikorska , James Uprichard Added: 3 years ago
For more than 50 years, oral vitamin K antagonists (VKAs) were the choice of anticoagulant for the long-term treatment and prevention of arterial and venous thromboembolic events (VTE). VKA treatment is safe and effective, if a high time in therapeutic range is achieved. However, achieving a stable, therapeutic international normalised ratio can prove challenging in the context of drug and food… View more

Anticoagulation

Prevention & Chronic Conditions
Role of Newer Oral Anticoagulants for Post-operative Prophylaxis
Author(s): Han Naung Tun , May Thu Kyaw , Erik Rafflenbeul , et al Added: 1 year ago

Anticoagulation

Vascular Disease and Surgery
Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?
Author(s): Mahmoud Abdelnabi , Abdallah Almaghraby , Yehia Saleh Added: 3 years ago
Vitamin K antagonist (VKA) oral anticoagulants have been ruling the field of anticoagulation for cardiovascular indications for years now. Recently, this dominance has been threatened by the introduction of direct oral anticoagulants (DOACs), with abundant data highlighting their safety and efficacy. To date, recent guidelines have limited the use of DOACs to stroke prevention in patients with… View more

Anticoagulation
Author(s): Antoni Martínez-Rubio , Mario DiazNuila-Alcazar , Anna Soria Cadena , et al Added: 3 years ago
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice in Western countries. The prevalence of AF depends on the population studied1 and especially on age.2–9 It is affected by increasing longevity and is modulated by the prevalence of cardiovascular risk factors, especially arterial hypertension and related habits. In Spain, for example, the prevalence of AF… View more

Anticoagulation
Direct Oral Anticoagulants Concentration Testing in Clinical Practice for High-Risk Patients with AF
Author(s): K Pukite , I Urtane , I Pupkevica , et al Added: 3 years ago
Aim: The aim of this study was to analyse the necessary of coagulation tests for AF patients with high cardiovascular risk in clinical practice. Design and methods: Quantitative, analytic, cross-sectional clinical study, during the period from April 2018 to February 2019, was performed at Pauls Stradins Clinical University Hospital, Cardiology Centre of Latvia. Data were collected on patients… View more

Electrophysiology & Arrhythmia
Author(s): Fernando Worner , Cristina Marzo , Kristian Rivera , et al Added: 3 years ago
Topic: 1. Clinical Cardiology Introduction Universal use of Directs Oral Anticoagulants (DOACs) in non valvular atrial fibrillation (nVAF) is not possible for economic reasons. Therefore, it is mandatory to guarantee their prescription of these drugs in patients theoretically most benefited. Objectives To review indications and results of one territorial, prospective and centralized… View more

Anticoagulation
APSC Consensus Recommendations on DOACs in Asian Patients with AF
Author(s): Daniel TT Chong , Felicita Andreotti , Peter Verhamme , et al Added: 2 years ago

Anticoagulation

Electrophysiology & Arrhythmia
Research Area(s) / Expertise:
Research Area(s) / Expertise: Job title: Professor of Cardiovascular Medicine
Prof Felicita Andreotti is a tenured Professor and Medical Director at the Gemelli IRCCS Hospital and Catholic University in Rome, Italy, where she currently coordinates cardiovascular research within the Scientific Directorate.Prof Andreotti gained her MD and two specialties - in respiratory and cardiac diseases - from the University of Strasbourg, France, and then Pisa, Italy. During her PhD… View more
Author(s): Ben Borokhovsky , Perry J Weinstock Added: 12 months ago

Anticoagulation

Electrophysiology & Arrhythmia